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Cutaneous reticulohistiocytosis is a rare form of
non-Langerhans cell histiocytosis.1 Zak2 originally
coined the term reticulohistiocytosis, which is now
used to describe the histologic pattern of multi-
nucleate giant cells and oncocytic macrophages
showing abundant eosinophilic, finely granular cyto-
plasm with a ground glass appearance.1 Clinically,
reticulohistiocytomas represent asymptomatic, yel-
low to red-brown or grey-white papules or nodules,
which tend to be solitary.3 Solitary reticulohistiocy-
tomas are regarded as benign and are found to occur
more commonly in young males but with no predi-
lection as to location.3 Reticulohistiocytomas are
rarely reported to occur in crops, then termed mul-
tiple reticulohistiocytomas. These crops show no
predilection to age, sex, or location and are thought
to be benign with the ability to spontaneously
regress.4-6 In contrast, multicentric reticulohistiocyto-
sis is a well-recognized systemic and aggressive form
of reticulohistiocytosis, which typically presents in
middle-age women with multiple widespread retic-
ulohistiocytomas and associated severe arthritis. This
disease can involve multiple organ systems and is
usually progressive, necessitating treatment with
systemic agents.7 Unlike solitary or multiple reticulo-
histiocytoma, multicentric reticulohistiocytosis can
represent a paraneoplastic phenomenon, with up to
25% of cases being associated with an underlying
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We present a 61-year-old white woman of
Hungarian background with a 10-month history of a
progressive asymptomatic eruption extending from
her left clavicle, up the left side of her neck, and
including the pre-auricular region. The eruption con-
sisted of multiple erythematous papules and nodules,
some of which coalesced to form large plaques
localized only to the left side of the neck overlying
the sternocleidomastoid muscle (Fig 1). No regional
lymphadenopathy was palpable. Her medical history
was significant for obesity, type 2 diabetes mellitus,
hypertension, hypercholesterolemia, depression, and
irritable bowel syndrome. Her regular medications
included insulin, amlodipine, and sertraline.
Results of a biopsy showed prominent interstitial
epithelioid histiocytes, some showing a ground glass
cytoplasm and a patchy lymphohistiocytic infiltrate
with fewplasma cells (Fig 2). Stains for acid-fast bacilli
and fungiwerenegative. Immunohistochemical stains
were positive for CD68, CD163, CD31, and Factor 13a
and negative for CD1a, S100, CD34, adipophilin and
erythroblast transformation-specific related gene.
Findings for full blood count, serum electrolytes,
and liver function tests were all within normal limits.JAAD Case Reports 2015;1:157-9.
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Fig 2. Reticulohistiocytoma, repeat skin biopsy. (Hema-
toxylin-eosin stain; original magnification: 320.)
Fig 3. Multiple cutaneous reticulohistiocytomas immedi-
ately after treatment with 4 months of topical PUVA
combined with intralesional injections of triamcinolone
acetonide every 3 months for 9 months.
Fig 1. Multiple cutaneous reticulohistiocytomas prior to
treatment.
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sedimentation rate were increased, and a small
paraprotein of the IgG lambda type was identified
in the serum.
A bonemarrow trephine and aspirate did not show
infiltration of histiocytes into the bone marrow, and
computed tomography scans of the chest, abdomen,
and pelvis showed no lymphadenopathy but did
show some degenerative changes in the left hip. On a
clinical and histopathologic basis, a diagnosis of
multiple cutaneous reticulohistiocytomas was made.
Treatment consisted of a series of 3 intralesional
injections, each containing 10 mg of a 5-mg/mL
solution of triamcinolone acetonide given 3 months
apart. Immediately after the second injection she was
additionally treated with topical application of 0.01%oxsoralen to the lesions followed by psoralen com-
bined with ultraviolet A (PUVA) therapy 3 times a
week for a total of 4 months. At the end of the 10-
month treatment regimen, there was a marked
reduction in the number, size, and height of the
papules and nodules (Fig 3).
DISCUSSION
The diagnosis and classification of the different
types of non-Langerhans cell histiocytoses are ever
changing with the development of new immuno-
histochemical techniques.9 There is a paucity of
documented cases of multiple cutaneous reticulo-
histiocytomas of the nonmulticentric type and a very
limited number presenting high-quality clinical pho-
tographs and potential therapeutic strategies to treat
the disease. Multiple cutaneous reticulohistiocyto-
mas have been successfully treated surgically and in
combinationwith electrodesiccation.5 This treatment
is favored for solitary lesions3 but was difficult to
justify in our patient because of the associated
morbidity of surgery on the head and neck to remove
multiple lesions and because the disease is generally
regarded as benign with the possibility of sponta-
neous regression.5 Topical PUVA therapy has been
used successfully in one case of multiple cutaneous
reticulohistiocytomas as a noninvasive method of
treatment.10 We used topical PUVA therapy in com-
bination with intralesional injections of triamcino-
lone acetonide, which led to a significant
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Harris et al 159improvement. We feel the temporality of the
improvement fits with a therapeutic response to the
described treatment, but spontaneous resolution
cannot be ruled out.
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